The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system - PubMed (original) (raw)
. 2006 Nov 24;281(47):35770-8.
doi: 10.1074/jbc.M608281200. Epub 2006 Sep 25.
Affiliations
- PMID: 17001073
- DOI: 10.1074/jbc.M608281200
Free article
The 19-amino acid cassette of cyclooxygenase-2 mediates entry of the protein into the endoplasmic reticulum-associated degradation system
Uri R Mbonye et al. J Biol Chem. 2006.
Free article
Abstract
Cyclooxygenase (COX) isoforms catalyze the committed step in prostaglandin biosynthesis. The primary structures of COX-1 and COX-2 are very similar except that COX-2 has a 19-amino acid (19-AA) segment of unknown function located just inside its C terminus. Here we provide evidence that the major role of the 19-AA cassette is to mediate entry of COX-2 into the ER-associated degradation system that transports ER proteins to the cytoplasm. COX-1 is constitutively expressed in many cells, whereas COX-2 is usually expressed inducibly and transiently. In murine NIH/3T3 fibroblasts, we find that COX-2 protein is degraded with a half-life (t(1/2)) of about 2 h, whereas COX-1 is reasonably stable (t(1/2) > 12 h); COX-2 degradation is retarded by 26 S proteasome inhibitors. Similarly, COX-1 expressed heterologously in HEK293 cells is quite stable (t(1/2) > 24 h), whereas COX-2 expressed heterologously is degraded with a t(1/2) of approximately 5 h, and its degradation is slowed by proteasome inhibitors. A deletion mutant of COX-2 was prepared lacking 18 residues of the 19-AA cassette. This mutant retains native COX-2 activity but, unlike native COX-2, is stable in HEK293 cells. Conversely, inserting the COX-2 19-AA cassette near the C terminus of COX-1 yields a mutant ins594-612 COX-1 that is unstable (t(1/2) approximately 3 h). Mutation of Asn-594, an N-glycosylation site at the beginning of the 19-AA cassette, stabilizes both COX-2 and ins594-612 COX-1; nonetheless, COX mutants that are glycosylated at Asn-594 but lack the remainder of the 19-amino acid cassette (i.e. del597-612 COX-2 and ins594-596 COX-1) are stable. Thus, although glycosylation of Asn-594 is necessary for COX-2 degradation, at least part of the remainder of the 19-AA insert is also required. Finally, kifunensine, a mannosidase inhibitor that can block entry of ER proteins into the ER-associated degradation system, retards COX-2 degradation.
Similar articles
- Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation.
Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL. Kang YJ, et al. Prog Lipid Res. 2007 Mar;46(2):108-25. doi: 10.1016/j.plipres.2007.01.001. Epub 2007 Jan 18. Prog Lipid Res. 2007. PMID: 17316818 Free PMC article. Review. - Two pathways for cyclooxygenase-2 protein degradation in vivo.
Wada M, Saunders TL, Morrow J, Milne GL, Walker KP, Dey SK, Brock TG, Opp MR, Aronoff DM, Smith WL. Wada M, et al. J Biol Chem. 2009 Nov 6;284(45):30742-53. doi: 10.1074/jbc.M109.052415. Epub 2009 Sep 16. J Biol Chem. 2009. PMID: 19758985 Free PMC article. - A cyclooxygenase-2-dependent prostaglandin E2 biosynthetic system in the Golgi apparatus.
Yuan C, Smith WL. Yuan C, et al. J Biol Chem. 2015 Feb 27;290(9):5606-20. doi: 10.1074/jbc.M114.632463. Epub 2014 Dec 29. J Biol Chem. 2015. PMID: 25548276 Free PMC article. - Two distinct pathways for cyclooxygenase-2 protein degradation.
Mbonye UR, Yuan C, Harris CE, Sidhu RS, Song I, Arakawa T, Smith WL. Mbonye UR, et al. J Biol Chem. 2008 Mar 28;283(13):8611-23. doi: 10.1074/jbc.M710137200. Epub 2008 Jan 18. J Biol Chem. 2008. PMID: 18203712 - Posttranscriptional and posttranslational determinants of cyclooxygenase expression.
Mbonye UR, Song I. Mbonye UR, et al. BMB Rep. 2009 Sep 30;42(9):552-60. doi: 10.5483/bmbrep.2009.42.9.552. BMB Rep. 2009. PMID: 19788855 Review.
Cited by
- Rapid degradation of cyclooxygenase-1 and hematopoietic prostaglandin D synthase through ubiquitin-proteasome system in response to intracellular calcium level.
Yazaki M, Kashiwagi K, Aritake K, Urade Y, Fujimori K. Yazaki M, et al. Mol Biol Cell. 2012 Jan;23(1):12-21. doi: 10.1091/mbc.E11-07-0623. Epub 2011 Nov 2. Mol Biol Cell. 2012. PMID: 22049022 Free PMC article. - Crystal Structure of Aspirin-Acetylated Human Cyclooxygenase-2: Insight into the Formation of Products with Reversed Stereochemistry.
Lucido MJ, Orlando BJ, Vecchio AJ, Malkowski MG. Lucido MJ, et al. Biochemistry. 2016 Mar 1;55(8):1226-38. doi: 10.1021/acs.biochem.5b01378. Epub 2016 Feb 19. Biochemistry. 2016. PMID: 26859324 Free PMC article. - Different Fatty Acids Compete with Arachidonic Acid for Binding to the Allosteric or Catalytic Subunits of Cyclooxygenases to Regulate Prostanoid Synthesis.
Dong L, Zou H, Yuan C, Hong YH, Kuklev DV, Smith WL. Dong L, et al. J Biol Chem. 2016 Feb 19;291(8):4069-78. doi: 10.1074/jbc.M115.698001. Epub 2015 Dec 23. J Biol Chem. 2016. PMID: 26703471 Free PMC article. - Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation.
Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL. Kang YJ, et al. Prog Lipid Res. 2007 Mar;46(2):108-25. doi: 10.1016/j.plipres.2007.01.001. Epub 2007 Jan 18. Prog Lipid Res. 2007. PMID: 17316818 Free PMC article. Review. - Two pathways for cyclooxygenase-2 protein degradation in vivo.
Wada M, Saunders TL, Morrow J, Milne GL, Walker KP, Dey SK, Brock TG, Opp MR, Aronoff DM, Smith WL. Wada M, et al. J Biol Chem. 2009 Nov 6;284(45):30742-53. doi: 10.1074/jbc.M109.052415. Epub 2009 Sep 16. J Biol Chem. 2009. PMID: 19758985 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials